The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients

dc.contributor.author	González Lara, Leire
dc.contributor.author	Batalla Cebey, Ana
dc.contributor.author	Coto García, Eliecer
dc.contributor.author	Gómez de Oña, Juan
dc.contributor.author	Eiris Salvado, Noemí
dc.contributor.author	Santos-Juanes Jiménez, Jorge
dc.contributor.author	Queiro Silva, Rubén
dc.contributor.author	Coto Segura, Pablo
dc.date.accessioned	2015-12-21T10:40:25Z
dc.date.available	2015-12-21T10:40:25Z
dc.date.issued	2015
dc.identifier.citation	Archives of Dermatological Research, 307(5), p. 405-412 (2015); doi:10.1007/s00403-014-1533-z
dc.identifier.issn	0340-3696
dc.identifier.uri	http://hdl.handle.net/10651/34425
dc.description.sponsorship	PI 13/00680, FEDER, Federación Española de Enfermedades Raras
dc.description.sponsorship	Spanish Instituto de Salud Carlos III-European FEDER founds (Grant PI 13/00680)
dc.format.extent	p. 405-412
dc.language.iso	eng
dc.relation.ispartof	Archives of Dermatological Research
dc.rights	© Springer-Verlag Berlin Heidelberg 2014
dc.source	Scopus
dc.source.uri	http://www.scopus.com/inward/record.url?eid=2-s2.0-84931566035&partnerID=40&md5=e54d4556b2a0ec78d7ff3255653e1eb2
dc.title	The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients	eng
dc.type	journal article
dc.identifier.doi	10.1007/s00403-014-1533-z
dc.relation.publisherversion	http://dx.doi.org/10.1007/s00403-014-1533-z

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.